EHC Earnings & Financial Statements
Encompass Health Corporation
$128.10
+$1.54(+1.22%)
81
Overall
85
Value
90
Tech
68
Quality
Market Cap
$12.49B
Volume
364.18K
52W Range
$92.77 - $127.99
Target Price
$146.54
EHC earnings and financial statements: Encompass Health Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
EHC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| Cost of revenue | $254.40M | $3.14B | $218.30M | $202.10M | $184.20M |
| Operating income | $1.44B | $921.80M | $788.10M | $684.90M | $777.40M |
| EBITDA | $1.41B | $1.20B | $1.03B | $879.80M | $1.01B |
| Net income | $566.20M | $455.70M | $352.00M | $271.00M | $412.20M |
| EPS (diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B |
| Total liabilities | $3.81B | $3.69B | $3.81B | $3.77B | $4.47B |
| Shareholders’ equity | $2.44B | $2.07B | $1.65B | $1.31B | $1.91B |
| Cash and equivalents | $72.20M | $85.40M | $69.10M | $21.80M | $49.40M |
| Long-term debt | $2.64B | $2.55B | $2.88B | $2.94B | $3.42B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.18B | $1.00B | $850.80M | $705.80M | $715.80M |
| Capital expenditure | -$736.40M | -$642.50M | -$583.10M | -$584.10M | -$545.70M |
| Free cash flow | $439.20M | $360.30M | $267.70M | $121.70M | $170.10M |
| Dividends paid | $71.10M | $62.80M | $60.40M | $99.00M | $112.20M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EHC | $128.10 | +1.2% | 364.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Encompass Health Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW